Details

SANGER DNA SEQUENCING<br> Sanger DNA sequencing (Men)<br> NEXT GENERATION SEQUENCING -<br> TOWARDS PERSONALIZED MEDICINE<br> Illumina Genome Analyzer II System (Lakdawalla)<br> Applied Biosystems SOLiD? System -<br> Ligation-based Sequencing (Prediger)<br> The next Generation Genome Sequencing: 454/Roche GS FLX (Egholm)<br> Polony Sequencing -<br> History, technology, and Applications (Edwards)<br> THE BOTTLENECK: SEQUENCE DATA ANALYSIS<br> Next Generation Sequence Data Analysis (Bloksberg)<br> DNASTARs Next Generation Software (Durfee)<br> EMERGING SEQUENCING TECHNOLOGIES<br> Real-time DNA sequencing (Hardin)<br> Direct Sequencing by TEM of Z-substituted DNA Molecules (Glover)<br> A Single DNA Molecule Barcoding Method with Applications in DNA Mapping and Molecular Haplotyping (Xao)<br> Optical Sequencing -<br> Acquisition from Mapped Single Molecule Templates (Schwartz)<br> Microchip-based Sanger Sequencing of DNA (Barron)<br> NEXT GENERATION SEQUENCING -<br> TRULY INTEGRATED GENOME ANALYSIS<br> Multiplex Sequencing of Paired End diTags for Transcriptome and Genome Analysis (Ruan)<br> Palaeogenomics using the 454 Sequencing Platform (Gilbert)<br> ChIPSeq: Mapping of Protein-DNA Interactions (Fejes)<br> MicroRNA Discovery and Expression Profiling using Next-generation Sequencing (Cuppen)<br> DeepSAGE -<br> Tag-based Transcriptome Analysis beyond Microarrays (Nielsen)<br> The new Genomics and Personal Genome Information: Ethical Issues (Lunshof)<br> <br> <br>

Dr. Michal Janitz is a group leader at the Department of Vertebrate Genomics at the Max Planck Institute for Molecular Genetics, Berlin. Dr. Janitz scientific interest is focused on technology development related to high-throughput functional genomics using cell array and nanowell-based oligonucleotide fingerprinting. Before joining the MPIMG Dr. Janitz was a postdoc at the German Rheumatism Research Center in Berlin where he also received a Ph.D on studies concerning functional analysis of the MHC class II promoters polymorphisms. He is a member of the German National Genome Research Network and Gerson Lehrman Group Healthcare & Biomedical Council.<br>

DE